Insmed Quarterly Balance Sheet
NASDAQ: INSMHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Insmed financial position
As of Jun 30, 2026, Insmed reported total assets of $2.10 billion, down 15.2% from a year earlier against total liabilities of $1.35 billion. Shareholders' equity stood at $757.5 million, or 36.0% of assets. The company held $544.8 million in cash and equivalents against $543.5 million of debt, a net cash position of $1.3 million.
The current ratio (current assets divided by current liabilities) was 3.72, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.72.
Summary generated from market data by MetaCap's automated system. Methodology
Insmed balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 544.76M | 582.19M | 510.44M | 334.76M | 1.28B | 403.25M | 555.03M | 461.45M | 1.25B | 595.73M | 482.37M | 487.11M |
| Short-Term Investments | 615.55M | 641.33M | 919.60M | 1.35B | 572.44M | 796.20M | 878.80M | 1.01B | 0 | 0 | 298.07M | 298.84M |
| Receivables | 215.32M | 178.56M | 140.86M | 65.26M | 55.03M | 47.75M | 52.01M | 42.32M | 40.30M | 37.16M | 41.19M | 35.58M |
| Inventory | 142.38M | 132.91M | 132.07M | 120.97M | 107.61M | 100.71M | 98.58M | 98.47M | 90.06M | 82.96M | 83.25M | 77.92M |
| Total Current Assets | 1.63B | 1.61B | 1.79B | 1.93B | 2.08B | 1.40B | 1.62B | 1.65B | 1.42B | 758.72M | 929.06M | 926.58M |
| Property, Plant & Equipment | 107.22M | 102.85M | 102.94M | 89.67M | 90.00M | 88.36M | 80.05M | 75.27M | 72.78M | 68.66M | 65.38M | 64.63M |
| Goodwill | 136.11M | 136.11M | 136.11M | 136.11M | 136.11M | 136.11M | 136.11M | 136.11M | 136.11M | 136.11M | 136.11M | 136.11M |
| Intangible Assets | 93.49M | 95.57M | 97.65M | 84.59M | 56.13M | 57.39M | 58.65M | 59.91M | 61.18M | 62.44M | 63.70M | 64.97M |
| Total Assets | 2.10B | 2.08B | 2.26B | 2.36B | 2.48B | 1.80B | 2.03B | 2.05B | 1.81B | 1.16B | 1.33B | 1.32B |
| Accounts Payable | 74.56M | 73.38M | 79.91M | 79.59M | 74.05M | 57.68M | 73.03M | 64.95M | 51.36M | 44.02M | 65.39M | 65.38M |
| Short-Term Debt | — | — | — | — | — | — | — | — | 224.45M | 224.19M | 0 | — |
| Total Current Liabilities | 438.74M | 361.01M | 468.87M | 417.21M | 311.68M | 239.23M | 297.53M | 259.19M | 524.15M | 420.86M | 225.63M | 196.73M |
| Long-Term Debt | 543.51M | 542.22M | 540.96M | 539.72M | 538.51M | 1.11B | 1.10B | 954.83M | 946.83M | 939.08M | 1.16B | 1.15B |
| Total Liabilities | 1.35B | 1.37B | 1.53B | 1.42B | 1.23B | 1.70B | 1.74B | 1.57B | 1.77B | 1.62B | 1.66B | 1.61B |
| Shareholders' Equity | 757.49M | 704.85M | 738.98M | 945.57M | 1.25B | 99.16M | 285.38M | 483.42M | 38.82M | -464.81M | -331.92M | -289.36M |
| Retained Earnings | -5.81B | -5.80B | -5.64B | -5.31B | -4.94B | -4.62B | -4.36B | -4.12B | -3.90B | -3.60B | -3.45B | -3.26B |
| Total Debt | 543.51M | 542.22M | 540.96M | 539.72M | 538.51M | 1.11B | 1.10B | 954.83M | 1.17B | 1.16B | 1.16B | 1.15B |
| Net Cash (Debt) | 616.80M | 681.30M | 889.08M | 1.14B | 1.32B | 94.38M | 330.44M | 513.08M | 75.53M | -567.55M | -374.87M | -361.57M |
| Shares Outstanding | 218.28M | 216.52M | 214.26M | 212.58M | 211.11M | 181.90M | 179.38M | 178.85M | 166.67M | 148.56M | 147.98M | 143.05M |
This table shows 12 quarterly periods of Insmed's balance sheet, from Q2 2026 back to Q3 2023, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow INSM's reporting calendar. What is a balance sheet?